The ratings agency also affirmed the “AA-/F1+” rating on the health system’s $265.6 million of series 2015A, 2015B and 2015C bonds.
The outlook has been revised to stable from positive.
More articles on healthcare finance:
S&P assigns ‘AA’ rating to Boston Children’s Hospital’s bonds
Moody’s assigns ‘Aa2’ rating to Boston Children’s Hospital’s bonds
11 recent hospital outlook and credit rating actions
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
